Literature DB >> 10559765

Health care concerns and guidelines for adults with Down syndrome.

M I van Allen1, J Fung, S B Jurenka.   

Abstract

Down syndrome (DS) is the most common cause of mental retardation in North America, yet little information is available on the natural history of DS in adults. We report on significant medical problems of adults with DS (DS adults) residing in a British Columbia provincial residential center, Woodlands, over the 12-year period from 1981 through 1992. Prospective, yearly health care reviews on 38 DS adults are summarized according to age. Group 1 consists of 18 middle-aged DS adults less than 50 years old, and group 2 comprises 20 elderly DS adults 50 years and older. Significant health problems in all DS adults include untreated congenital heart anomalies (15. 8%), acquired cardiac disease (15.8%), pulmonary hypertension (7.8%), recurrent respiratory infections/aspiration leading to chronic pulmonary interstitial changes (30%), complications from presenile dementia/Alzheimer-type disease (42%), adult-onset epilepsy (36.8%), osteoarthritic degeneration of the spine (31.6%), osteoporosis with resultant fractures of the long bones (55%) or vertebral bodies (30%), and untreated atlantooccipital instability (7.9%). Acquired sensory deficits are significant problems including loss of vision due to early onset of adult cataracts (50%), recurrent keratitis (21%) or keratoconus (15.8%), and significant hearing loss (25%). Behavioral problems (50%), loss of cognitive abilities, and onset of symptoms of Alzheimer disease (group 1: 5.5%; group 2: 75%) pose ongoing challenges for care. In conclusion, the quality of life for adults with DS can be improved by routine, systematic health care screening to identify treatable diseases that may be missed because of poor communication or confusion due to Alzheimer disease. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  1999        PMID: 10559765

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  27 in total

1.  Bone mineral mass in males and females with and without Down syndrome.

Authors:  Fatima Baptista; Ana Varela; Luis B Sardinha
Journal:  Osteoporos Int       Date:  2004-09-09       Impact factor: 4.507

2.  Health conditions associated with aging and end of life of adults with Down syndrome.

Authors:  Anna J Esbensen
Journal:  Int Rev Res Ment Retard       Date:  2010

Review 3.  Aneuploidy and skeletal health.

Authors:  Archana Kamalakar; John R Harris; Kent D McKelvey; Larry J Suva
Journal:  Curr Osteoporos Rep       Date:  2014-09       Impact factor: 5.096

4.  Adults with Down's syndrome: the prevalence of complications and health care in the community.

Authors:  Alex Henderson; Sally A Lynch; Steve Wilkinson; Morag Hunter
Journal:  Br J Gen Pract       Date:  2007-01       Impact factor: 5.386

5.  Non-psychiatric health problems among psychiatric inpatients with intellectual disabilities.

Authors:  L Charlot; S Abend; P Ravin; K Mastis; A Hunt; C Deutsch
Journal:  J Intellect Disabil Res       Date:  2011-02

Review 6.  Neurological phenotypes for Down syndrome across the life span.

Authors:  Ira T Lott
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

7.  Low bone turnover and low bone density in a cohort of adults with Down syndrome.

Authors:  K D McKelvey; T W Fowler; N S Akel; J A Kelsay; D Gaddy; G R Wenger; L J Suva
Journal:  Osteoporos Int       Date:  2012-08-18       Impact factor: 4.507

8.  Hospitalizations among people with Down syndrome: a nationwide population-based study in Denmark.

Authors:  Jin Liang Zhu; Henrik Hasle; Adolfo Correa; Diana Schendel; J M Friedman; Jørn Olsen; Sonja A Rasmussen
Journal:  Am J Med Genet A       Date:  2013-02-12       Impact factor: 2.802

9.  Rule-based category learning in Down syndrome.

Authors:  B Allyson Phillips; Frances A Conners; Edward Merrill; Mark R Klinger
Journal:  Am J Intellect Dev Disabil       Date:  2014-05

10.  Sleep problems and associated comorbidities among adults with Down syndrome.

Authors:  A J Esbensen
Journal:  J Intellect Disabil Res       Date:  2015-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.